
Brian J. Gangle
Examiner (ID: 511, Phone: (571)272-1181 , Office: P/1645 )
| Most Active Art Unit | 1645 |
| Art Unit(s) | 1645 |
| Total Applications | 1233 |
| Issued Applications | 798 |
| Pending Applications | 132 |
| Abandoned Applications | 327 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16313792
[patent_doc_number] => 20200292530
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-17
[patent_title] => CELL-BASED ASSAY USING ELECTROPHYSIOLOGICAL ACTIVITY MEASURED WITH MICROELECTRODE ARRAYS
[patent_app_type] => utility
[patent_app_number] => 16/813053
[patent_app_country] => US
[patent_app_date] => 2020-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6229
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16813053
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/813053 | Cell-based assay using electrophysiological activity measured with microelectrode arrays | Mar 8, 2020 | Issued |
Array
(
[id] => 16359434
[patent_doc_number] => 20200316185
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-08
[patent_title] => VACCINES AND METHODS OF VACCINATION AGAINST SCHISTOSOMA
[patent_app_type] => utility
[patent_app_number] => 16/812212
[patent_app_country] => US
[patent_app_date] => 2020-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32832
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16812212
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/812212 | VACCINES AND METHODS OF VACCINATION AGAINST SCHISTOSOMA | Mar 5, 2020 | Abandoned |
Array
(
[id] => 18869835
[patent_doc_number] => 11857615
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-01-02
[patent_title] => Peptides derived from
[patent_app_type] => utility
[patent_app_number] => 16/809011
[patent_app_country] => US
[patent_app_date] => 2020-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 52246
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 166
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16809011
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/809011 | Peptides derived from | Mar 3, 2020 | Issued |
Array
(
[id] => 17805930
[patent_doc_number] => 20220257765
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-18
[patent_title] => TARGET-SPECIFIC CONJUGATE AND USE THEREFOR
[patent_app_type] => utility
[patent_app_number] => 17/435455
[patent_app_country] => US
[patent_app_date] => 2020-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7858
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17435455
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/435455 | TARGET-SPECIFIC CONJUGATE AND USE THEREFOR | Mar 1, 2020 | Abandoned |
Array
(
[id] => 16267324
[patent_doc_number] => 20200268811
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-27
[patent_title] => METHODS AND COMPOSITIONS FOR TREATMENT OF MICROBIOME-ASSOCIATED DISORDERS
[patent_app_type] => utility
[patent_app_number] => 16/804285
[patent_app_country] => US
[patent_app_date] => 2020-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 48736
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16804285
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/804285 | Methods and compositions for treatment of microbiome-associated disorders | Feb 27, 2020 | Issued |
Array
(
[id] => 19870354
[patent_doc_number] => 12263192
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-04-01
[patent_title] => Compositions for management of disorders of the gastrointestinal tract
[patent_app_type] => utility
[patent_app_number] => 17/433723
[patent_app_country] => US
[patent_app_date] => 2020-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 40
[patent_figures_cnt] => 60
[patent_no_of_words] => 67432
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17433723
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/433723 | Compositions for management of disorders of the gastrointestinal tract | Feb 25, 2020 | Issued |
Array
(
[id] => 16312335
[patent_doc_number] => 20200291073
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-17
[patent_title] => CATIONIC NEUROTOXINS
[patent_app_type] => utility
[patent_app_number] => 16/800109
[patent_app_country] => US
[patent_app_date] => 2020-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18534
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16800109
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/800109 | Cationic neurotoxins | Feb 24, 2020 | Issued |
Array
(
[id] => 16640894
[patent_doc_number] => 10918715
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-02-16
[patent_title] => Treatment of severe community acquired pneumonia
[patent_app_type] => utility
[patent_app_number] => 16/786639
[patent_app_country] => US
[patent_app_date] => 2020-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 21655
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16786639
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/786639 | Treatment of severe community acquired pneumonia | Feb 9, 2020 | Issued |
Array
(
[id] => 16224114
[patent_doc_number] => 20200249231
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-06
[patent_title] => SYSTEM AND METHOD FOR IDENTIFICATION AND CHARACTERIZATION OF TRANSGLUTAMINASE SPECIES
[patent_app_type] => utility
[patent_app_number] => 16/785406
[patent_app_country] => US
[patent_app_date] => 2020-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19976
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16785406
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/785406 | System and method for identification and characterization of transglutaminase species | Feb 6, 2020 | Issued |
Array
(
[id] => 16204844
[patent_doc_number] => 20200237834
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-30
[patent_title] => COMPOSITIONS COMPRISING BACTERIAL STRAINS
[patent_app_type] => utility
[patent_app_number] => 16/784958
[patent_app_country] => US
[patent_app_date] => 2020-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18537
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16784958
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/784958 | COMPOSITIONS COMPRISING BACTERIAL STRAINS | Feb 6, 2020 | Abandoned |
Array
(
[id] => 16009235
[patent_doc_number] => 20200179460
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-11
[patent_title] => Reducing the Likelihood of Skin Cancer in an Individual Human Being
[patent_app_type] => utility
[patent_app_number] => 16/782364
[patent_app_country] => US
[patent_app_date] => 2020-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20929
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16782364
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/782364 | Reducing the likelihood of skin cancer in an individual human being | Feb 4, 2020 | Issued |
Array
(
[id] => 16221283
[patent_doc_number] => 20200246399
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-06
[patent_title] => COMPOSITION FOR INDUCING PROLIFERATION OR ACCUMULATION OF REGULATORY T CELLS
[patent_app_type] => utility
[patent_app_number] => 16/780116
[patent_app_country] => US
[patent_app_date] => 2020-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22196
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16780116
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/780116 | Composition for inducing proliferation or accumulation of regulatory T cells | Feb 2, 2020 | Issued |
Array
(
[id] => 15965497
[patent_doc_number] => 20200166500
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-28
[patent_title] => UNMASKING ENDOTOXINS IN SOLUTION
[patent_app_type] => utility
[patent_app_number] => 16/776855
[patent_app_country] => US
[patent_app_date] => 2020-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29773
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16776855
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/776855 | Unmasking endotoxins in solution | Jan 29, 2020 | Issued |
Array
(
[id] => 15960089
[patent_doc_number] => 20200163796
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-28
[patent_title] => Method and System for Reducing the Likelihood of Colorectal Cancer in a Human Being
[patent_app_type] => utility
[patent_app_number] => 16/776861
[patent_app_country] => US
[patent_app_date] => 2020-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13636
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16776861
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/776861 | Method and system for reducing the likelihood of colorectal cancer in a human being | Jan 29, 2020 | Issued |
Array
(
[id] => 17198656
[patent_doc_number] => 20210338750
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-04
[patent_title] => METHOD FOR PROTECTING A SUBJECT FOR EXERCISE
[patent_app_type] => utility
[patent_app_number] => 17/285983
[patent_app_country] => US
[patent_app_date] => 2020-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3288
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17285983
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/285983 | Method for protecting a subject for exercise | Jan 21, 2020 | Issued |
Array
(
[id] => 16270163
[patent_doc_number] => 20200271650
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-27
[patent_title] => ANTIBODY TO CYTOLETHAL DISTENDING TOXIN OF CAMPYLOBACTER JEJUNI
[patent_app_type] => utility
[patent_app_number] => 16/734842
[patent_app_country] => US
[patent_app_date] => 2020-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11278
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16734842
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/734842 | ANTIBODY TO CYTOLETHAL DISTENDING TOXIN OF CAMPYLOBACTER JEJUNI | Jan 5, 2020 | Abandoned |
Array
(
[id] => 19638075
[patent_doc_number] => 12168676
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-12-17
[patent_title] => Microbially derived peptides and proteins for immunotherapy
[patent_app_type] => utility
[patent_app_number] => 17/420813
[patent_app_country] => US
[patent_app_date] => 2020-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 34
[patent_no_of_words] => 20734
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17420813
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/420813 | Microbially derived peptides and proteins for immunotherapy | Jan 5, 2020 | Issued |
Array
(
[id] => 20192241
[patent_doc_number] => 20250268951
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-08-28
[patent_title] => THERAPEUTIC AND PROPHYLACTIC USE OF MICROORGANISMS
[patent_app_type] => utility
[patent_app_number] => 17/417732
[patent_app_country] => US
[patent_app_date] => 2019-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25905
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17417732
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/417732 | THERAPEUTIC AND PROPHYLACTIC USE OF MICROORGANISMS | Dec 26, 2019 | Pending |
Array
(
[id] => 16523751
[patent_doc_number] => 20200397831
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-24
[patent_title] => USE OF AKKERMANSIA IN THE TREATMENT OF ORAL DISEASES
[patent_app_type] => utility
[patent_app_number] => 16/724672
[patent_app_country] => US
[patent_app_date] => 2019-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18463
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16724672
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/724672 | USE OF AKKERMANSIA IN THE TREATMENT OF ORAL DISEASES | Dec 22, 2019 | Abandoned |
Array
(
[id] => 20171797
[patent_doc_number] => 12390517
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-08-19
[patent_title] => Compositions, methods and uses for eliciting an immune response
[patent_app_type] => utility
[patent_app_number] => 17/416271
[patent_app_country] => US
[patent_app_date] => 2019-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 5
[patent_no_of_words] => 22237
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 135
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17416271
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/416271 | Compositions, methods and uses for eliciting an immune response | Dec 19, 2019 | Issued |